These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6611926)

  • 1. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
    Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
    Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic pharmaceuticals for magnetic resonance imaging.
    Wesbey GE; Engelstad BL; Brasch RC
    Physiol Chem Phys Med NMR; 1984; 16(2):145-55. PubMed ID: 6095341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
    Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
    Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
    Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study.
    Lönnemark M; Hemmingsson A; Bach-Gansmo T; Ericsson A; Oksendal A; Nyman R; Moxnes A
    Acta Radiol; 1989; 30(2):193-6. PubMed ID: 2923745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR imaging oral contrast agent mixed with milk for the small intestine].
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies.
    Hahn PF; Stark DD; Saini S; Lewis JM; Wittenberg J; Ferrucci JT
    Radiology; 1987 Jul; 164(1):37-41. PubMed ID: 3588924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans.
    Mattrey RF; Hajek PC; Gylys-Morin VM; Baker LL; Martin J; Long DC; Long DM
    AJR Am J Roentgenol; 1987 Jun; 148(6):1259-63. PubMed ID: 3495156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
    Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
    J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of nitrosyl-iron complexes: experimental study in rats.
    Fichtlscherer B; Mülsch A
    Radiology; 2000 Jul; 216(1):225-31. PubMed ID: 10887252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electronmicroscopic-histochemical demonstration of acid mucopolysaccharides using cationic ferrocenyl compounds (author's transl)].
    Franz H; Pfüller U; Glöckner R
    Acta Histochem; 1978; 61(1):64-71. PubMed ID: 150189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
    Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
    Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.